May 7, 2007
Lee Biosolutions has announced the availability of Human Hemoglobin to clinical researchers worldwide.
Hemoglobin is the molecule in red blood cells that combines with oxygen in the lungs and is responsible for releasing it into the tissues.
Mutations in the genes for the human hemoglobin protein are the cause of a group of hereditary diseases called the hemoglobinopathies. The most common of these diseases are sickle-cell disease and thalassemia. The hemoglobinopathy of sickle-cell disease was the first disease to be understood in its mechanism of dysfunction, completely down to the molecular level.
Hemoglobin levels are among the most routinely ordered blood tests, typically as part of a complete blood count.
Human hemoglobin is the latest in a long line of products the company has introduced recently to meet the demands of clinical research professionals.
More information can be found on the company’s Web site.
